Analyst Reco. CARsgen Therapeutics Holdings Limited

Equities

Delayed Hong Kong S.E. Other stock markets 04:52:58 02/07/2024 BST			5-day change	1st Jan Change
4.56 ^HKD	-5.00%		-7.69%	-29.85%

06-27	CARsgen Therapeutics' Substantial Shareholder Boosts Stake to 37.78%	MT
06-15	CARsgen Therapeutics Holdings Limited Presents First-In-Human Results of GPRC5D Targeting CAR-T CT071 At EHA 2024	CI

UBS Adjusts CARsgen Therapeutics' Price Target to HK$34.50 From HK$38, Keeps at Buy	25/08/22	MT
UBS Adjusts CARsgen Therapeutics' Price Target to HK$38 From HK$53, Keeps at Buy	14/04/22	MT

No results for this search